Navigation Links
Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor
Date:5/8/2008

Dana-Farber and Colorado Treating Patients with ENMD-2076

ROCKVILLE, Md., May 8 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that Dana-Farber Cancer Institute has joined the University of Colorado Cancer Center in conducting a Phase 1 study of ENMD-2076 in advanced cancer patients. Dr. Geoffrey Shapiro, Dana-Farber Cancer Institute, and Dr. Wells Messersmith, University of Colorado Cancer Center, will serve as co-principal investigators for the study.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Safety and tolerability of orally administered ENMD-2076 in refractory cancer patients will be assessed in this Phase 1 study. A secondary objective for the study will be to determine a dose-dependent response to treatment with ENMD-2076 through the evaluation of pharmacokinetic parameters.

ENMD-2076 is a novel, selective kinase inhibitor with potent activity against Aurora A and tyrosine kinases linked to the promotion of cancer and inflammatory diseases. ENMD-2076 acts through multiple pathways, resulting in both antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated substantial, dose-dependent efficacy as a single agent in multiple preclinical models, including tumor regression in breast, colon, and leukemia models. Importantly, ENMD-2076 is an oral agent that has shown an acceptable toxicity profile in preclinical studies without cardiovascular toxicity.

Carolyn F. Sidor, MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the study, "Both clinical trial sites are now enrolling and treating patients with our selective kinase inhibitor. We believe that this product candidate has substantial potential as both a single agent and in
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Altern...hina, announced today that, the,Health Services B...uspended,the use of 83 doses of inactivated hepat...the death of a minor in the Fengtai District on No...tration of the vaccine two days prior. , Th...
(Date:12/2/2008).... 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) ...technology and medical device,research and develo... and the,United States, today announced it will d...s expanding biologics testing, cell banking and ce... WuXi will discontinue its U.S.,biologics manufac...
(Date:12/2/2008)... Major biopharmaceutical companies with subst...are forecast to have adequate internal manufacturi...acturers (CMOs) however, are likely to feel the pr...MOs and biopharmaceutical companies depending on t... factors and manufacturing trends is instrumental ...
(Date:12/1/2008)...exas, Dec. 1, 2008 Imagine a self-powering cell p...verts sound waves produced by the user into the en...ched as it may seem thanks to the recent work of T...rtment of Chemical Engineering at Texas A&M Univer...circles as "piezoelectrics," Cagin, whose research...
Breaking Biology Technology:Sinovac Releases Statement on Healive Vaccine Suspension 2WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 2WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 3WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 4WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 5PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013 2Self-powered devices possible, says Texas A&M researcher 2Self-powered devices possible, says Texas A&M researcher 3
...eplay into a real environment, the city of Madison.... Firefighters need to be fully prepared, practi...e fire. City officials need to respond to a chemic...n to the right place. Military teams need to work ...alties. , ,These high-risk jobs now have virtual t...
...er of higher education institutions created the Un... a perfect marriage, insist those who pine for day...eration and prompted wiser use of Wisconsins publi...em to once again refine its structure, this time w... budget crunch, rising tuition costs and changing ...
...uncement that it plans to buy its former parent A...heir eyes open for new opportunities. , ,Drew Pete...ecom , said the merger between SBC and AT&T is a s...communications rather than a regional one. TDS, wh...western company, is keeping an eye out for any new...
...ed January a notoriously depressing month because...d dank weather thats no surprise. In fact, an Eng... one week ago) was the most depressing day of the ...ar an extra psychological burden because of the ch...calated last month for reasons that have nothing t...
Other Biology Technology:How games have evolved to provide real-world education 2How games have evolved to provide real-world education 3How games have evolved to provide real-world education 4Structural change is coming to the UW System 2Structural change is coming to the UW System 3SBC merger with AT&T could open opportunities in Wisconsin 2Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4
(Date:12/2/2008)..., WEST LAFAYETTE, Ind. - Researchers at Purdue U...aser and holograms to precisely position numerous ...ntial new tool to analyze biological samples or cr..., called rapid electrokinetic patterning, is a pot...e the patterns can be more quickly and easily chan...
(Date:12/2/2008)..., With their sedentary lifestyles and filter-feed...e changes that humans have inflicted upon their wa... H. Carmichael of the Dauphin Island Sea Lab and h...in the prestigious journal Aquatic Biology . Usi...ted it is possible to identify and trace wastewate...
(Date:12/2/2008)... New Haven, Conn.Organizations in the United State...e from climate change are not adapting enough to t... to a Yale report. , "Despite a half century of ...cted temperature and precipitation patterns and ha...al impacts, and despite a near certainty that the ...
(Date:12/2/2008)... African cities are growing faster than anywhere e...ut few ecologists are studying the urban environme... most important ecological changes in Africa,s his... University of Twente has reviewed the problem in ...gy . She says "A hundred years ago 95% of the Afri...
Breaking Biology News(10 mins):New holographic method could be used for lab-on-a-chip technologies 2New holographic method could be used for lab-on-a-chip technologies 3New holographic method could be used for lab-on-a-chip technologies 4Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors 7136 1Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors 7136 2System of Simplified Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communica 7133 1System of Simplified Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communica 7133 2System of Simplified Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communica 7133 3Warning Beware of Counterfeit Coda 28R 29 Products 7130 1Warning Beware of Counterfeit Coda 28R 29 Products 7130 2Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference 1987 1
... Mary Lee Dequeant, Ph.D., a Predoctoral Researche...nd Olivier Pourquié, Ph.D., Stowers Institute Inve...s Medical Institute, are the first and last author...ork of cyclic genes that shed light on the molecul... paper was published on Science Express, the advan...
... Scientists are using genetic studies and natural ... further our knowledge on how genetic and early mo...hose early interactions can be manipulated to stav...h new and promising chemopreventive agents were pr...earch,s Frontiers in Cancer Prevention Research me...
... Global warming strikes again. A University of Ill...ird population in Ontario, Canada has decreased by... a positive shift in the North Atlantic Oscillatio...the southeastern United States. , When Patrick Wea... black bird alongside climate records, he found a ...
... Mayo Clinic researchers have found that a protein...ell division also directs cell death for those cel...esents a potential "bulls eye" for targeting anti-...sue of Science. , The researchers examined a prote...works as a "quality control inspector." As normal ...
Other Biology News:Plant-derived molecules, genetic manipulation point to future chemoprevention methods 2Plant-derived molecules, genetic manipulation point to future chemoprevention methods 3Plant-derived molecules, genetic manipulation point to future chemoprevention methods 4Plant-derived molecules, genetic manipulation point to future chemoprevention methods 5Climate change creates dramatic decline in red-winged black bird population 2Mayo discovers protein as potential tactic to prevent tumors 2
... electronic pressure controller available measurin...cifically for the analytical instrumentation and l...control, microfluidic flow control, gas-over-liqui...ic focusing, the OEM-EPC offers external pressure ...
... the same benefits as the VSO valve with enhanced ...tical or flow is required below 600 sccm. This min...of gas in proportion to the input current., , Use...sed loop feedback delivers optimal system performa...
Silencer GAPDH siRNA Control Template Kit from Ambion
Serum is obtained from non-demolished blood that is collected from healthy, fasted donors. The donors are not medicated in any way and are maintained on an antibiotic free diet. Total Protein Concen
Biology Products: